Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-04-01 @ 9:53 PM
Study NCT ID:
NCT01609127
Status:
UNKNOWN
Last Update Posted:
2012-06-01
First Post:
2012-05-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer
Sponsor:
Genta Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-05
Start Date Type:
None
Primary Completion Date:
2013-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2014-07
Completion Date Type:
ESTIMATED
First Submit Date:
2012-05-25
First Submit QC Date:
None
Study First Post Date:
2012-05-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-05-31
Last Update Post Date:
2012-06-01
Last Update Post Date Type:
ESTIMATED